This report contains market size and forecasts of Chronic Liver Diseases Therapeutics in Global, including the following market information:
Global Chronic Liver Diseases Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chronic Liver Diseases Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Liver Diseases Therapeutics include Astellas Pharma, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, F. Hoffmann-La Roche, Merck, Novartis, Sanofi and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Liver Diseases Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Liver Diseases Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chronic Liver Diseases Therapeutics Market Segment Percentages, by Type, 2021 (%)
Chemotherapy Drugs
Targeted Therapy
Vaccines
Antiviral Drugs
Immunoglobulins
Corticosteroids
Others
Global Chronic Liver Diseases Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chronic Liver Diseases Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Chronic Liver Diseases Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chronic Liver Diseases Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Liver Diseases Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chronic Liver Diseases Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
F. Hoffmann-La Roche
Merck
Novartis
Sanofi
Pfizer
Takeda Pharmaceutical
Bausch Health
Theratechnologies
Alnylam Pharmaceuticals
Protagonist Therapeutics
Dicerna Pharmaceuticals
Endo International
Provectus Biopharmaceuticals
MAX BioPharma